| BP0164-25MG
| InVivoPlus anti-mouse CTLA-4 (CD152)
| 25 mg
| BioXCell
| in vivo CTLA-4 neutralization, Western blot
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0075-100MG
| InVivoPlus anti-mouse Ly6G/Ly6C (Gr-1)
| 100 mg
| BioXCell
| in vivo depletion of Gr-1+ myeloid cells, Flow cyt
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0307-50MG
| InVivoPlus anti-mouse CD16/CD32
| 50 mg
| BioXCell
| in vitro Fc receptor blocking, in vivo Fc receptor
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0055-5MG
| InVivoPlus anti-mouse IFN?
| 5 mg
| BioXCell
| in vivo IFN? neutralization, in vitro IFN? neutral
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0003-1-50MG
| InVivoPlus anti-mouse CD4
| 50 mg
| BioXCell
| in vivo CD4+ T cell depletion, Flow cytometry, Wes
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0290-50MG
| InVivoPlus rat IgG1 isotype control, anti-trinitrophenol
| 50 mg
| BioXCell
|
|
| Rat
| Rat
| Solicitar Precio
| Solicitar
|
| BP0297-100MG
| InVivoPlus human IgG1 isotype control
| 100 mg
| BioXCell
|
|
| Human
|
| Solicitar Precio
| Solicitar
|
| BP0036-100MG
| InVivoPlus anti-mouse NK1.1
| 100 mg
| BioXCell
| in vivo NK cell depletion, Flow cytometry
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0083-25MG
| InVivoPlus mouse IgG1 isotype control, unknown specificity
| 25 mg
| BioXCell
|
|
| Mouse
|
| Solicitar Precio
| Solicitar
|
| BP0131-50MG
| InVivoPlus anti-mouse CTLA-4 (CD152)
| 50 mg
| BioXCell
| in vivo CTLA-4 neutralization, in vitro CTLA-4 neu
|
| Syrian Hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0088-25MG
| InVivoPlus rat IgG1 isotype control, anti-horseradish peroxidase
| 25 mg
| BioXCell
|
|
| Rat
|
| Solicitar Precio
| Solicitar
|
| BP0301-100MG
| InVivoPlus human IgG2 isotype control
| 100 mg
| BioXCell
|
|
| Human
|
| Solicitar Precio
| Solicitar
|
| BP0017-1-5MG
| InVivoPlus anti-mouse CD40L (CD154)
| 5 mg
| BioXCell
| in vivo blocking of CD40/CD40L signaling, in vitro
|
| Armenian Hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0101-50MG
| InVivoPlus anti-mouse PD-L1 (B7-H1)
| 50 mg
| BioXCell
| in vivo PD-L1 blockade, Immunofluorescence, Immuno
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0004-1-100MG
| InVivoPlus anti-mouse CD8?
| 100 mg
| BioXCell
| in vivo CD8+ T cell depletion, Immunofluorescence,
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0091-5MG
| InVivoPlus polyclonal Armenian hamster IgG
| 5 mg
| BioXCell
|
|
| Armenian Hamster
|
| Solicitar Precio
| Solicitar
|
| BP0017-1-100MG
| InVivoPlus anti-mouse CD40L (CD154)
| 100 mg
| BioXCell
| in vivo blocking of CD40/CD40L signaling, in vitro
|
| Armenian Hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0032-5MG
| InVivoPlus anti-mouse CTLA-4 (CD152)
| 5 mg
| BioXCell
| in vivo CTLA-4 neutralization, in vitro CTLA-4 neu
|
| Armenian Hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0101-25MG
| InVivoPlus anti-mouse PD-L1 (B7-H1)
| 25 mg
| BioXCell
| in vivo PD-L1 blockade, Immunofluorescence, Immuno
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0273-25MG
| InVivoPlus anti-mouse PD-1 (CD279)
| 25 mg
| BioXCell
| in vivo blocking of PD-1/PD-L signaling, in vitro
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0308-50MG
| InVivoPlus anti-rat CD4
| 50 mg
| BioXCell
| in vivo CD4+ T cell depletion, Flow cytometry
|
| Mouse
| Rat
| Solicitar Precio
| Solicitar
|
| BP0085-100MG
| InVivoPlus mouse IgG2a isotype control, unknown specificity
| 100 mg
| BioXCell
|
|
| Mouse
|
| Solicitar Precio
| Solicitar
|
| BP0032-100MG
| InVivoPlus anti-mouse CTLA-4 (CD152)
| 100 mg
| BioXCell
| in vivo CTLA-4 neutralization, in vitro CTLA-4 neu
|
| Armenian Hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0239-25MG
| InVivoPlus anti-mouse 4-1BB (CD137)
| 25 mg
| BioXCell
| in vivo 4-1BB stimulation, in vitro 4-1BB stimulat
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0117-100MG
| InVivoPlus anti-mouse CD8?
| 100 mg
| BioXCell
| in vivo CD8+ T cell depletion, Western blot
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0274-25MG
| InVivoPlus anti-mouse TIGIT
| 25 mg
| BioXCell
| in vivo TIGIT stimulation, Flow cytometry
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0079-50MG
| InVivoPlus anti-human MHC Class I (HLA-A, HLA-B, HLA-C)
| 50 mg
| BioXCell
| Functional assays
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BP0075-25MG
| InVivoPlus anti-mouse Ly6G/Ly6C (Gr-1)
| 25 mg
| BioXCell
| in vivo depletion of Gr-1+ myeloid cells, Flow cyt
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0088-5MG
| InVivoPlus rat IgG1 isotype control, anti-horseradish peroxidase
| 5 mg
| BioXCell
|
|
| Rat
|
| Solicitar Precio
| Solicitar
|
| BP0307-25MG
| InVivoPlus anti-mouse CD16/CD32
| 25 mg
| BioXCell
| in vitro Fc receptor blocking, in vivo Fc receptor
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0115-25MG
| InVivoPlus anti-mouse TIM-3 (CD366)
| 25 mg
| BioXCell
| in vivo TIM-3 neutralization, in vitro TIM-3 block
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0099-5MG
| InVivoPlus recombinant CTLA-4-Ig (hum/hum)
| 5 mg
| BioXCell
|
|
|
|
| Solicitar Precio
| Solicitar
|
| BP0329-5MG
| InVivoPlus anti-mouse CD71 (TfR1)
| 5 mg
| BioXCell
| in vivo depletion of CD71+ cells, Immunofluorescen
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0085-25MG
| InVivoPlus mouse IgG2a isotype control, unknown specificity
| 25 mg
| BioXCell
|
|
| Mouse
|
| Solicitar Precio
| Solicitar
|
| BP0174-50MG
| InVivoPlus anti-mouse LAG-3
| 50 mg
| BioXCell
| in vivo LAG-3 neutralization, in vitro LAG-3 neutr
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0099-25MG
| InVivoPlus recombinant CTLA-4-Ig (hum/hum)
| 25 mg
| BioXCell
|
|
|
|
| Solicitar Precio
| Solicitar
|
| BP0115-50MG
| InVivoPlus anti-mouse TIM-3 (CD366)
| 50 mg
| BioXCell
| in vivo TIM-3 neutralization, in vitro TIM-3 block
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0003-3-5MG
| InVivoPlus anti-mouse CD4
| 5 mg
| BioXCell
| in vivo blockade of CD4+ T-cell responses, Western
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0051-50MG
| InVivoPlus anti-mouse IL-12 p40
| 50 mg
| BioXCell
| in vivo IL-12p40 neutralization, p40 affinity chro
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0131-25MG
| InVivoPlus anti-mouse CTLA-4 (CD152)
| 25 mg
| BioXCell
| in vivo CTLA-4 neutralization, in vitro CTLA-4 neu
|
| Syrian Hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0274-100MG
| InVivoPlus anti-mouse TIGIT
| 100 mg
| BioXCell
| in vivo TIGIT stimulation, Flow cytometry
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0075-1-5MG
| InVivoPlus anti-mouse Ly6G
| 5 mg
| BioXCell
| in vivo neutrophil depletion, in vivo MDSC depleti
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0173-100MG
| InVivoPlus anti-mouse IL-17A
| 100 mg
| BioXCell
| in vivo IL-17A neutralization
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0089-50MG
| InVivoPlus rat IgG2a isotype control, anti-trinitrophenol
| 50 mg
| BioXCell
|
|
| Rat
|
| Solicitar Precio
| Solicitar
|
| BP0099-50MG
| InVivoPlus recombinant CTLA-4-Ig (hum/hum)
| 50 mg
| BioXCell
|
|
|
|
| Solicitar Precio
| Solicitar
|
| BP0301-25MG
| InVivoPlus human IgG2 isotype control
| 25 mg
| BioXCell
|
|
| Human
|
| Solicitar Precio
| Solicitar
|
| BP0075-1-50MG
| InVivoPlus anti-mouse Ly6G
| 50 mg
| BioXCell
| in vivo neutrophil depletion, in vivo MDSC depleti
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0175-100MG
| InVivoPlus anti-mouse CD71 (TfR1)
| 100 mg
| BioXCell
| in vivo depletion of CD71+ cells
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0164-100MG
| InVivoPlus anti-mouse CTLA-4 (CD152)
| 100 mg
| BioXCell
| in vivo CTLA-4 neutralization, Western blot
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0063-50MG
| InVivoPlus anti-mouse GITR
| 50 mg
| BioXCell
| in vivo GITR stimulation
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|